Annual FCF
-$43.75 M
+$5.29 M+10.79%
31 December 2023
Summary:
Leap Therapeutics annual free cash flow is currently -$43.75 million, with the most recent change of +$5.29 million (+10.79%) on 31 December 2023. During the last 3 years, it has fallen by -$17.80 million (-68.56%). LPTX annual FCF is now -469.70% below its all-time high of -$7.68 million, reached on 31 December 2012.LPTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$15.60 M
-$1.93 M-14.11%
30 September 2024
Summary:
Leap Therapeutics quarterly free cash flow is currently -$15.60 million, with the most recent change of -$1.93 million (-14.11%) on 30 September 2024. Over the past year, it has dropped by -$5.11 million (-48.74%). LPTX quarterly FCF is now -277.13% below its all-time high of $8.81 million, reached on 31 December 2015.LPTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$55.17 M
-$5.11 M-10.21%
30 September 2024
Summary:
Leap Therapeutics TTM free cash flow is currently -$55.17 million, with the most recent change of -$5.11 million (-10.21%) on 30 September 2024. Over the past year, it has dropped by -$8.78 million (-18.93%). LPTX TTM FCF is now -2959.73% below its all-time high of -$1.80 million, reached on 31 March 2013.LPTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | -48.7% | -18.9% |
| 3 y3 years | -68.6% | -92.5% | -81.3% |
| 5 y5 years | -68.1% | -124.2% | -95.9% |
LPTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -68.6% | +10.8% | -92.5% | at low | -81.3% | at low |
| 5 y | 5 years | -68.6% | +10.8% | -297.4% | at low | -129.3% | at low |
| alltime | all time | -469.7% | +10.8% | -277.1% | at low | -2959.7% | at low |
Leap Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.60 M(+14.1%) | -$55.17 M(+10.2%) |
| June 2024 | - | -$13.67 M(-11.9%) | -$50.05 M(+7.5%) |
| Mar 2024 | - | -$15.52 M(+49.5%) | -$46.57 M(+6.4%) |
| Dec 2023 | -$43.75 M(-10.8%) | -$10.38 M(-1.0%) | -$43.75 M(-5.7%) |
| Sept 2023 | - | -$10.49 M(+3.0%) | -$46.39 M(-3.7%) |
| June 2023 | - | -$10.19 M(-19.8%) | -$48.15 M(-4.1%) |
| Mar 2023 | - | -$12.70 M(-2.4%) | -$50.23 M(+2.4%) |
| Dec 2022 | -$49.04 M(+39.5%) | -$13.01 M(+6.2%) | -$49.04 M(+4.9%) |
| Sept 2022 | - | -$12.25 M(-0.0%) | -$46.75 M(+9.7%) |
| June 2022 | - | -$12.26 M(+6.4%) | -$42.59 M(+11.8%) |
| Mar 2022 | - | -$11.52 M(+7.5%) | -$38.09 M(+8.3%) |
| Dec 2021 | -$35.16 M(+35.4%) | -$10.72 M(+32.3%) | -$35.16 M(+15.5%) |
| Sept 2021 | - | -$8.10 M(+4.5%) | -$30.43 M(+5.2%) |
| June 2021 | - | -$7.75 M(-9.7%) | -$28.92 M(-5.5%) |
| Mar 2021 | - | -$8.59 M(+43.4%) | -$30.62 M(+18.0%) |
| Dec 2020 | -$25.96 M(-3.9%) | -$5.99 M(-9.2%) | -$25.96 M(+0.4%) |
| Sept 2020 | - | -$6.59 M(-30.3%) | -$25.86 M(-1.4%) |
| June 2020 | - | -$9.45 M(+140.7%) | -$26.23 M(+9.0%) |
| Mar 2020 | - | -$3.93 M(-33.4%) | -$24.06 M(-10.9%) |
| Dec 2019 | -$27.00 M(+3.7%) | -$5.89 M(-15.3%) | -$27.00 M(-4.1%) |
| Sept 2019 | - | -$6.96 M(-4.5%) | -$28.16 M(-1.7%) |
| June 2019 | - | -$7.28 M(+6.0%) | -$28.65 M(+4.5%) |
| Mar 2019 | - | -$6.87 M(-2.6%) | -$27.42 M(+5.3%) |
| Dec 2018 | -$26.03 M | -$7.05 M(-5.4%) | -$26.03 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$7.45 M(+23.1%) | -$25.35 M(+25.2%) |
| June 2018 | - | -$6.05 M(+10.5%) | -$20.25 M(-4.7%) |
| Mar 2018 | - | -$5.48 M(-14.0%) | -$21.27 M(-4.2%) |
| Dec 2017 | -$22.20 M(-12.9%) | -$6.37 M(+170.4%) | -$22.20 M(-4.0%) |
| Sept 2017 | - | -$2.35 M(-66.7%) | -$23.14 M(-17.8%) |
| June 2017 | - | -$7.06 M(+10.1%) | -$28.15 M(+1.5%) |
| Mar 2017 | - | -$6.41 M(-12.2%) | -$27.73 M(+8.8%) |
| Dec 2016 | -$25.48 M(+214.5%) | -$7.30 M(-0.9%) | -$25.48 M(+172.0%) |
| Sept 2016 | - | -$7.37 M(+11.0%) | -$9.37 M(+23.8%) |
| June 2016 | - | -$6.64 M(+59.5%) | -$7.57 M(+14.3%) |
| Mar 2016 | - | -$4.16 M(-147.3%) | -$6.62 M(-18.3%) |
| Dec 2015 | -$8.10 M(-55.6%) | $8.81 M(-258.2%) | -$8.10 M(-64.1%) |
| Sept 2015 | - | -$5.57 M(-2.2%) | -$22.56 M(+1.5%) |
| June 2015 | - | -$5.69 M(+0.8%) | -$22.22 M(+6.4%) |
| Mar 2015 | - | -$5.65 M(-0.1%) | -$20.88 M(+14.4%) |
| Dec 2014 | -$18.24 M(+81.4%) | -$5.65 M(+8.0%) | -$18.24 M(+11.0%) |
| Sept 2014 | - | -$5.23 M(+20.3%) | -$16.44 M(+25.0%) |
| June 2014 | - | -$4.35 M(+44.4%) | -$13.15 M(+16.7%) |
| Mar 2014 | - | -$3.01 M(-21.6%) | -$11.26 M(+12.0%) |
| Dec 2013 | -$10.05 M(+30.9%) | -$3.84 M(+97.3%) | -$10.05 M(+61.8%) |
| Sept 2013 | - | -$1.95 M(-21.0%) | -$6.21 M(+45.6%) |
| June 2013 | - | -$2.46 M(+36.6%) | -$4.27 M(+136.6%) |
| Mar 2013 | - | -$1.80 M | -$1.80 M |
| Dec 2012 | -$7.68 M | - | - |
FAQ
- What is Leap Therapeutics annual free cash flow?
- What is the all time high annual FCF for Leap Therapeutics?
- What is Leap Therapeutics annual FCF year-on-year change?
- What is Leap Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Leap Therapeutics?
- What is Leap Therapeutics quarterly FCF year-on-year change?
- What is Leap Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Leap Therapeutics?
- What is Leap Therapeutics TTM FCF year-on-year change?
What is Leap Therapeutics annual free cash flow?
The current annual FCF of LPTX is -$43.75 M
What is the all time high annual FCF for Leap Therapeutics?
Leap Therapeutics all-time high annual free cash flow is -$7.68 M
What is Leap Therapeutics annual FCF year-on-year change?
Over the past year, LPTX annual free cash flow has changed by +$5.29 M (+10.79%)
What is Leap Therapeutics quarterly free cash flow?
The current quarterly FCF of LPTX is -$15.60 M
What is the all time high quarterly FCF for Leap Therapeutics?
Leap Therapeutics all-time high quarterly free cash flow is $8.81 M
What is Leap Therapeutics quarterly FCF year-on-year change?
Over the past year, LPTX quarterly free cash flow has changed by -$5.11 M (-48.74%)
What is Leap Therapeutics TTM free cash flow?
The current TTM FCF of LPTX is -$55.17 M
What is the all time high TTM FCF for Leap Therapeutics?
Leap Therapeutics all-time high TTM free cash flow is -$1.80 M
What is Leap Therapeutics TTM FCF year-on-year change?
Over the past year, LPTX TTM free cash flow has changed by -$8.78 M (-18.93%)